Antibody blockade of TNF-α reduces inflammation and scarring in experimental crescentic glomerulonephritis

Kidney International

Volumn 67, Issue 5, 2005, Pages 1812-1820

  Khan, Sarah B ^a   Cook, H Terence ^a   Bhangal, Gurjeet ^a   Smith, Jennifer ^a   Tam, Frederick W K ^a   Pusey, Charles D ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Crescentic glomerulonephritis; Fibrosis; Glomerular basement membrane (GBM); Nephrotoxic nephritis; Tumour necrosis factor (TNF ); Wistar Kyoto (WKY) rat

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLOCKING ANTIBODY; COLLAGEN TYPE 4; CREATININE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EPITHELIUM CELL; IMMUNE COMPLEX NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; MACROPHAGE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RAT;

EID: 17744382183     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00279.x     Document Type: Article

References (34)

1. BAZZONI F, BEUTLER B: The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725, 1996
2. CHEN G, GOEDDEL DV: TNF-R1 signaling: A beautiful pathway. Science 296:1634-1635, 2002
3. CHAN KF, SIEGEL MR, LENARDO JM: Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13:419-422, 2000
4. SHARIEF MK, HENTGES R: Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472, 1991
5. SAKLATVALA J: Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549, 1986
6. STEVENS C, WALZ G, SINGARAM C, et al: Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818-826, 1992
7. KAM LY, TARGAN SR: TNF-alpha antagonists for the treatment of Crohn's disease. Expert Opin Pharmacother 1:615-622, 2000
8. FELDMANN M, MAINI RN: Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 19:163-196, 2001
9. TARGAN SR, HANAUER SB, VAN DEVENTER SJ, et al: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337:1029-1035, 1997
10. TAKEMURA T, YOSHIOKA K, MURAKAMI K, et al: Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 424:459-464, 1994
11. GOMEZ-CHIARRI M, ORTIZ A, LERMA JL, et al: Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70:449-459, 1994
12. BERTANI T, ABBATE M, ZOJA C, et al: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 134:419-430, 1989
13. TOMOSUGI NI, CASHMAN SJ, HAY H, et al: Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol 142:3083-3090, 1989
14. KARKAR AM, SMITH J, PUSEY CD: Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant 16:518-524, 2001
15. KARKAR AM, TAM FW, STEINKASSERER A, et al: Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int 48:1738-1746, 1995
16. LAN HY, YANG N, METZ C, et al: TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136-144, 1997
17. LE HIR M, HAAS C, MARINO M, RYFFEL B: Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 78:1625-1631, 1998
18. TIMOSHANKO JR, SEDGWICK JD, HOLDSWORTH SR, TIPPING PG: Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 14:1785-1793, 2003
19. GUO G, MORRISSEY J, MCCRACKEN R, et al: Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766-F772, 1999
20. GUO G, MORRISSEY J, MCCRACKEN R, TOLLEY T, et al: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 280:F777-F785, 2001
21. MULLIGAN MS, JOHNSON KJ, TODD RF, III, et al: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
22. TAM FW, SMITH J, MOREL D, et al: Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol Dial Transplant 14:1658-1666, 1999
23. ALLEN AR, MCHALE J, SMITH J, et al: Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol 162:5519-5527, 1999
24. COOK HT, KHAN SB, ALLEN A, et al: Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Am J Pathol 161:1265-1272, 2002
25. BHAN AK, SCHNEEBERGER EE, COLLINS AB, MCCLUSKEY RT: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med 148:246-260, 1978
26. BAKER FJ, SILVERTON RE: An Introduction to Medical Laboratory Technology, London, Butterworth, 1966
27. HANAUER SB, FEAGAN BG, LICHTENSTEIN GR, et al: Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 359:1541-1549, 2002
28. D'HAENS G, SWIJSEN C, NOMAN M, et al: Etanercept in the treatment of active refractory Crohn's disease: A single-center pilot trial. Am J Gastroenterol 96:2564-2568, 2001
29. ZHANG K, GHARAEE-KERMANI M, MCGARRY B, et al: TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol 158:954-959, 1997
30. LIU JY, BRASS DM, HOYLE GW, BRODY AR: TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 153:1839-1847, 1998
31. WANG Y, CHEN J, CHEN L, et al: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8:1537-1545, 1997
32. ROVIN BH, RUMANCIK M, TAN L, DICKERSON J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71:536-542, 1994
33. HAO L, OKADA H, KANNO Y, et al: Direct contact between human peripheral blood mononuclear cells and renal fibroblasts facilitates the expression of monocyte chemoattractant protein-1. Am J Nephrol 23:208-213, 2003
34. BOOTH A, HARPER L, HAMMAD T, et al: Prospective study of TNF-α blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15:717-721, 2004